Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis.
Kosuke MatsumotoJunko HiroharaAkihito TakeuchiRyo MiuraYoshinari AsaokaToshiaki NakanoAtsushi TanakaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
In patients with PBC receiving combination therapy, prognostic variables were similar to those in patients receiving UDCA monotherapy. These results indicate the importance of diagnosing patients with PBC at an earlier stage because of the reduced effectiveness of BZF at advanced stages. This article is protected by copyright. All rights reserved.